Latest Health News

Medical Developments International has reported a remarkable turnaround in FY25, posting a net profit after tax and securing paediatric approval for its flagship product Penthrox in Europe.

Medical Developments International Ltd reported an 18% increase in revenue to $39.1 million for FY25, returning to profitability with a net profit after tax of $0.1 million. The company advanced its Penthrox market expansion through regulatory approvals and new partnerships.

Medical Developments International reports a strong FY25 with significant margin gains and strategic progress, setting the stage for accelerated Penthrox expansion in FY26.

Downer EDI Limited has announced a fully franked ordinary dividend of AUD 0.141 per share for the six months ending June 2025, with payments scheduled for early October.

Whitehaven Coal Limited has announced a fully franked ordinary dividend of AUD 0.06 per share for the six months ending June 2025, signaling steady returns for shareholders.

Qube Holdings Limited has announced a fully franked ordinary dividend of AUD 0.057 per share for the six months ending June 2025, signaling steady shareholder returns amid a stable operational period.

Artrya Limited has secured FDA 510(k) clearance for its Salix Coronary Plaque module, enabling near real-time detection of high-risk coronary artery plaque and opening a lucrative U.S. market opportunity with a $950 reimbursement per scan.

Redox Ltd reported a robust 9.4% increase in revenue for FY25, supported by strong volume growth and three strategic acquisitions, despite margin compression and a challenging macroeconomic backdrop.

IPH Limited reported a solid 16.5% revenue increase to $710.3 million for FY25, driven by strategic acquisitions in Canada and strong organic growth in Asia and ANZ. Despite ongoing delays at the Canadian Intellectual Property Office, the company achieved higher earnings and dividends, setting the stage for further operational efficiencies and technology investments.

Insignia Financial delivered a robust FY25 performance with an 18% rise in underlying net profit after tax, driven by higher funds under management and cost efficiencies, while announcing a $3.3 billion acquisition agreement with CC Capital Partners.

Mitchell Services reported a transitional FY25 with revenue growth but earnings pressure from lower utilisation and mobilisation costs. The company secured key contracts and launched a decarbonisation joint venture, positioning for a stronger FY26.

Bega Cheese Limited has announced a fully franked ordinary dividend of AUD 0.06 per share for the half-year ending June 2025, alongside a Dividend Reinvestment Plan offering shareholders a choice to reinvest without discount.